Synergy CHC Corp. SNYR 深 沪
等待开盘 12-19 09:30:00 美东时间
1.80
-0.120
-6.25%
华盛通- 最 高1.944
- 今 开1.9168
- 成交量 2.80万股
- 最 低 1.80
- 昨 收 1.92
- 总市值 1622.54万
- 52周最高 4.98
- 市盈率 静 7.23
- 换手率 0.31%
- 52周最低 1.30
- 委 比 98.76%
- 总股本 901.41万
- 历史最高 10.00
- 量 比 1.38
- 振 幅 7.50%
- 历史最低 1.30
- 每 手 1
- 风险率 0.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania
Synergy CHC Corp. has announced new Direct Store Delivery (DSD) partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co. These agreements will expand the distribution of their FOCUSfactor functional beverages and brain-health shots in Maine and Pennsylvania. The partnerships support the company's strategy to build a nationwide DSD network, enhancing its retail footprint and accelerating FOCUSfactor's growth. Each dis...
12-15 13:00
Synergy CHC Launches $5.69M At-The-Market Offering Of Common Stock
Synergy CHC Corp.Up to $5,690,000Common StockWe have entered into a sales agreement with Roth Capital Partners, LLC (the "Lead Agent") and Bancroft Capital LLC (an "Agent" and together with the Lead Agent the "Agents")
12-10 05:39
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
Roth Capital Maintains Buy on Synergy CHC, Lowers Price Target to $7
Roth Capital analyst Sean McGowan maintains Synergy CHC (NASDAQ:SNYR) with a Buy and lowers the price target from $10 to $7.
11-15 01:41
Synergy CHC Q3 EPS $0.01, Inline, Sales $8.010M Miss $10.900M Estimate
Synergy CHC (NASDAQ:SNYR) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 90.91 percent decrease over earnings of $0.11 per share from the same period last year. The
11-13 21:03
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
Synergy CHC Corp. partners with C&M Sales to expand FOCUSfactor® functional beverages across Arkansas, leveraging their 90 years of expertise and 3,500+ accounts. FOCUSfactor® emphasizes science-backed brain health benefits, driving growth in the functional beverage market. Synergy CHC Corp. develops consumer health products, including FOCUSfactor® and Flat Tummy®. C&M Sales, founded in 1935, is a family-owned distributor with a strong pr...
11-05 13:00
Synergy CHC Corp. (NASDAQ: SNYR) Announces FOCUSfactor® Named #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026
Synergy CHC Corp.'s FOCUSfactor® has been named the #1 pharmacist-recommended OTC memory supplement for 2025-2026, according to Pharmacy Times survey. The recognition highlights FOCUSfactor's commitment to brain health and consumer trust, reflecting pharmacists' confidence in the brand. With over 20 years of leadership, FOCUSfactor continues to expand its presence in brain health and wellness markets.
10-27 12:00
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
<p>Synergy CHC Corp. has announced significant retail expansions for its FOCUSfactor® products across the U.S., Canada, and international markets, targeting demand for clean energy, brain health, and cognitive performance support. In the U.S., Kroger will launch three FOCUSfactor® SKUs in 1,600 stores, while Wakefern Food Corp., Velocity, RL Jordan Oil, and Seasons Cobia will introduce FOCUSfactor® beverages in multiple locations. In Canada, Unip...
10-22 12:00
